HTG Molecular Diagnostics Highlights Article Linked to its T

HTG Molecular Diagnostics Highlights Article Linked to its Transcriptome Panel in Bladder Cancer

HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) today highlighted a peer reviewed journal article featuring the HTG Transcriptome Panel (HTP) less than one year after the breakthrough product’s commercial release.

Related Keywords

Frankfurt , Brandenburg , Germany , John Lubniewski , Transcriptome Panel , University Hospital Frankfurt , Htg Molecular Diagnostics Inc , Molecular Diagnostics Inc , Nasdaq ,

© 2025 Vimarsana